Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Biomarkers to predict the clinical efficacy of bevacizumab in cancer

Biomarkers to predict the clinical efficacy of bevacizumab in cancer http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Oncology Unpaywall

Biomarkers to predict the clinical efficacy of bevacizumab in cancer

The Lancet OncologyNov 30, 2010
Loading next page...
 
/lp/unpaywall/biomarkers-to-predict-the-clinical-efficacy-of-bevacizumab-in-cancer-vxiHtZ0AFc

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
1470-2045
DOI
10.1016/s1470-2045(10)70232-1
Publisher site
See Article on Publisher Site

Abstract

Journal

The Lancet OncologyUnpaywall

Published: Nov 30, 2010

There are no references for this article.